Dolly (sheep)
Dolly was cloned by Keith Campbell, Ian Wilmut and colleagues at the Roslin Institute, part of the University of Edinburgh, Scotland, and the biotechnology company PPL Therapeutics, based near Edinburgh. The funding for Dolly's cloning was provided by PPL Therapeutics and the Ministry of Agriculture. She was born on 5 July 1996 and died from a progressive lung disease five months before her seventh birthday (the disease was not considered related to her being a clone). She has been called "the world's most famous sheep" by sources including BBC News and "Scientific American".
Ian Wilmut
Wilmut was the leader of the research group that in 1996 first cloned a mammal, a lamb named Dolly. Dolly died of a respiratory disease in 2003. However, in 2008 Wilmut announced that he would abandon the technique of somatic cell nuclear transfer by which Dolly was created in favour of an alternative technique developed by Shinya Yamanaka. This method has been used in mice to derive pluripotent stem cells from differentiated adult skin cells, thus circumventing the need to generate embryonic stem cells. Wilmut believes that this method holds greater potential for the treatment of degenerative conditions such as Parkinson's disease and to treat stroke and heart attack patients.